Free Trial

Amedisys (AMED) Earnings Date, Estimates & Call Transcripts

Amedisys logo
$96.25 +0.25 (+0.26%)
Closing price 05/5/2025 04:00 PM Eastern
Extended Trading
$96.59 +0.34 (+0.36%)
As of 05/5/2025 06:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amedisys Earnings Summary

Upcoming Q2
Earnings Date
Jul. 23Before Market OpensEstimated
Consensus EPS
(Apr. 23)
$1.13
Actual EPS
(Apr. 23)
$1.25 Beat By $0.12
Actual Revenue
(Apr. 23)
$594.78M

Amedisys posted Q1 2025 earnings on April 23, 2025, reporting an EPS of $1.25, which topped analysts' consensus estimates of $1.13 by $0.12. Quarterly revenue rose 4.1% year-over-year to $594.78 million, below analyst estimates of $597.43 million. With a trailing EPS of $2.71 and a P/E Ratio of 38.19, Amedisys' earnings are expected to grow 10.00% next year, from $4.40 to $4.84 per share.

Q1 2025 Earnings Resources

AMED Upcoming Earnings

Amedisys' next earnings date is estimated for Wednesday, July 23, 2025, based on past reporting schedules.

Get Amedisys Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amedisys and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AMED Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AMED Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Amedisys Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252$0.98$1.20$1.09
Q2 20252$1.32$1.50$1.41
Q3 20252$1.05$1.17$1.11
Q4 20252$1.04$1.11$1.08
FY 2025 8 $4.39 $4.98 $4.69
Q1 20261$1.24$1.24$1.24
Q2 20261$1.54$1.54$1.54
Q3 20261$1.20$1.20$1.20
Q4 20261$1.08$1.08$1.08

Amedisys Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/23/2025
(Estimated)
--------
4/23/2025Q1 2025$1.13$1.25+$0.12$1.84$597.43M$594.78M
2/26/2025Q4 2024$1.05$0.96 -$0.09-$0.62$602.38M$598.05M
11/6/2024Q3 2024$1.19$1.00 -$0.19$1.49$586.75M$587.67M
7/24/2024Q2 2024$1.22$1.32+$0.10$1.66$579.34M$591.19M
4/24/2024Q1 2024$1.02$1.03+$0.01$1.62$565.38M$571.41M
2/21/2024Q4 2023$1.04$0.94 -$0.10$1.29$566.85M$570.79M
10/24/2023Q3 2023$1.08$0.98 -$0.10$1.17$560.23M$556.24M
7/26/2023Q2 2023$1.09$1.37+$0.28$5.20$568.18M$552.97M

Amedisys Earnings - Frequently Asked Questions

Amedisys has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 23rd, 2025 based off last year's report dates. Learn more on AMED's earnings history.

In the previous quarter, Amedisys (NASDAQ:AMED) reported $1.25 earnings per share (EPS) to beat the analysts' consensus estimate of $1.13 by $0.12. Learn more on analysts' earnings estimate vs. AMED's actual earnings.

Amedisys's earnings report can be found in their filing with the SEC.
View SEC filing

Amedisys (NASDAQ:AMED) has a recorded annual revenue of $2.37 billion.

Amedisys (NASDAQ:AMED) has a recorded net income of -$9.75 million. AMED has generated $2.71 earnings per share over the last four quarters.

Amedisys (NASDAQ:AMED) has a trailing price-to-earnings ratio of 38.19 and a forward price-to-earnings ratio of 21.88. The price/earnings-to-growth ratio is 1.78.

Amedisys's earnings are expected to grow from $4.40 per share to $4.84 per share in the next year, which is a 10.00% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:AMED) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners